Real-time Influenza Vaccine Surveillance
NCT01233388 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2012-06-12
Summary
The aim of this proposal is to pioneer the implementation and evaluation of a novel patient centered text messaging vaccine adverse event surveillance network.
Conditions
- Vaccine Safety
Interventions
- OTHER
-
Text message surveillance
Text message surveillance for vaccine adverse events
Sponsors & Collaborators
-
Centers for Disease Control and Prevention
collaborator FED - lead OTHER
Principal Investigators
-
Philip LaRussa, MD · Columbia University
-
Melissa Stockwell, MD MPH · Columbia University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-11-30
- Primary Completion
- 2012-05-31
- Completion
- 2012-05-31
Countries
- United States
Study Locations
More Related Trials
-
Immune Response to High-Dose vs. Standard Dose Influenza Vaccine
NCT02297542 ·Status: UNKNOWN ·Phase: PHASE4
-
Inactivated Influenza Vaccine in Infants 10-22 Weeks of Age
NCT00231920 ·Status: COMPLETED ·Phase: PHASE1
-
Collaborative Efforts to Increase Flu Vaccination
NCT01403649 ·Status: COMPLETED ·Phase: NA
-
Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England
NCT03278067 ·Status: COMPLETED
-
FeverText: Assessing Fever Rates After Vaccination During the 2011-12 Influenza Season Using Text Messaging
NCT01467934 ·Status: COMPLETED
-
Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults
NCT03743688 ·Status: COMPLETED
-
Age and Response to Flu Vaccines
NCT03328325 ·Status: COMPLETED ·Phase: PHASE4
-
Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines
NCT02893878 ·Status: COMPLETED
-
Influenza Vaccine in Pediatric Transplant Subjects
NCT00133510 ·Status: COMPLETED ·Phase: PHASE4
-
Rapid Evaluation of Seasonal Influenza Vaccine
NCT00966342 ·Status: WITHDRAWN ·Phase: PHASE1
-
Adult Influenza Vaccination Text Message Reminders With Electronic Health Record Alerts
NCT02284594 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults
NCT00973349 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) （Children Forms of Drug）
NCT01551823 ·Status: COMPLETED ·Phase: PHASE3
-
Inpatient Influenza Surveillance
NCT00419861 ·Status: COMPLETED
-
Flu Shot Pre-visit Questionnaire
NCT05508698 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity of Influenza Vaccinations
NCT06518577 ·Status: COMPLETED ·Phase: PHASE4
-
FLUAD® vs. Fluzone® High-Dose Study
NCT03183908 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Text Message for Influenza Vaccination
NCT01761734 ·Status: COMPLETED ·Phase: NA
-
Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A
NCT03315104 ·Status: COMPLETED ·Phase: PHASE2
-
Protection From Influenza: Determining the Impact of Prior Infection
NCT03004040 ·Status: UNKNOWN
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects
NCT00329927 ·Status: COMPLETED ·Phase: PHASE2
-
Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014)
NCT02141581 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel
NCT03331991 ·Status: COMPLETED
-
Evaluating the Safeness of Trivalent Subunit Inactivated Influenza Vaccines in Preventing Flu on Vietnamese Volunteers
NCT01123954 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of FLU-v in an H1N1 Influenza Human Challenge Model
NCT03180801 ·Status: COMPLETED ·Phase: PHASE2